uThe last days of Taurus season make themselves known this week, hitting the snooze button and begging for just a few more hours of rest. Meanwhile, with Venus and Mercury clamouring for attention and stimulation in Gemini, rest isn’t really on the itinerary. Of course, just because something’s not on the schedule doesn’t mean it’s not available to those who demand it. With the shadow of Mercury retrograde in full effect and the imminence of the Sun’s ingress into Gemini, communication is key if anyone expects to get their needs met — but, we all know how tricky communication can be in a shadow period.
On May 21st, the Sun in Gemini will square Jupiter in Pisces, an aspect that’s sure to have us negotiating our expectations. On the collective front, our relationship to knowledge is changing. International issues that were once framed as “conflicts” or “arguments” are reframed within a larger narrative of colonisation and suppression, whether it’s Israel’s inhumane occupation of Palestine, the ongoing war against ethnic Armenians in Azerbaijan, or the uprising against police violence in Colombia. We are called to reckon with our role in, our relationship with, our endorsement of the information that is shared and information that’s suppressed.
Like what you see? How about some more R29 goodness, right here?
Egypt's highest civilian court on Monday upheld death sentences against 12 senior Muslim Brotherhood figures over a 2013 sit-in which ended with security forces killing hundreds of protesters, judicial sources said. The ruling, which cannot be appealed against, means the 12 men could face execution pending approval by President Abdel Fattah al-Sisi. Many Muslim Brotherhood figures have been sentenced to death in other cases related to the unrest that followed the military's ousting of Brotherhood president Mohamed Mursi in 2013, but the Court of Cassation ordered retrials.
QUEBEC CITY, Jun 14, 2021--Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series for Vancouver to discuss its latest investor presentation today, June 14 at 13:00pm PT. Devonian Health Group Inc. welc
The International Boxing Association commissioned an investigation into possible corruption and match-fixing at the 2016 Olympic tournament Monday, with just over a month before the next Olympics in Tokyo. The AIBA has hired Richard McLaren, who detailed Russian doping and cover-ups before the 2016 Olympics in Rio de Janeiro, to lead the investigation. “Our team will conduct an independent investigation into the questions surrounding corruption or manipulation of sporting results during the Rio Olympic Games, identify the persons responsible and recommend the appropriate course of action,” McLaren said in a statement.
CHICAGO, Jun 14, 2021--Northern Trust Corporation announced today that it will webcast its second quarter 2021 earnings conference call live on Wednesday, July 21, 2021. The webcast, the earnings press release and related presentation materials will be accessible on Northern Trust’s website.
VANCOUVER, British Columbia, Jun 14, 2021--HSBC has been selected by the Government of Canada's Department of Finance as one of two structuring advisors for its inaugural issuance of green bonds – the first of multiple milestones in advance of issuing Canada’s inaugural green bond in 2021-22.
Dividend stocks might not be exciting, but they usually generate more stable returns than volatile growth stocks. Enrolling those stocks into dividend reinvestment plans and then leaving them alone for decades can generate dazzling total returns as they compound their gains. Instead, they should invest in stable companies with sustainable payout ratios and low valuations.
PARIS & DIJON, France, Jun 14, 2021--Regulatory News: Servier and Oncodesign (Paris:ALONC) (ALONC – FR0011766229) today announced the selection of a preclinical candidate resulting from their strategic collaboration to find new treatments for Parkinson’s disease.